5-Amino-1MQ Daily Dosage Subcutaneous: What the Research Actually Shows

What is the typical 5-amino-1MQ daily dosage subcutaneous researchers report? Compare study doses, self-reported protocols, and safety caveats.

ARTICLE OVERVIEW

What is the typical 5-amino-1MQ daily dosage subcutaneous researchers report? Compare study doses, self-reported protocols, and safety caveats.

There is no established human 5-amino-1MQ daily dosage subcutaneous protocol. Rodent studies used roughly 5 mg per kilogram per day, while self-reported human use is usually described as a few hundred micrograms to about 1-2 mg per day. Because 5-amino-1MQ is sold as a research chemical and is not an approved drug, every dose you see online is experimental rather than clinical advice.

What 5-Amino-1MQ Is

5-Amino-1MQ is a synthetic inhibitor of nicotinamide N-methyltransferase, or NNMT, an enzyme involved in NAD+ metabolism and fat cell signaling. In mice, blocking NNMT has been linked to reduced fat mass and improved metabolic markers.

Almost all published evidence comes from animals, not people. The compound is commonly sold as a lyophilized powder labeled "for research use only," which is why users mix it with bacteriostatic water and inject it under the skin.

What the Research Shows About Dosing

Animal studies are the only controlled source of dosing information that exists. Researchers have typically given 5-amino-1MQ to diet-induced obese mice at about 5 mg/kg per day and observed reductions in body weight and fat mass over several weeks.

Those results cannot be converted into a human equivalent dose with any confidence. Mice and humans differ in absorption, metabolism, clearance, and tissue response, and no published human pharmacokinetic study exists for this compound.

ContextReported amountRouteEvidence quality
Published rodent study~5 mg/kg per dayOral gavage or intraperitonealPeer-reviewed animal data
Self-reported human use (lower range)~250-500 mcg per daySubcutaneousAnecdote only
Self-reported human use (higher range)~1-2 mg per daySubcutaneousAnecdote only
Oral self-experimentationOften reported as much larger than injectable amountsOralAnecdote only

Why Subcutaneous Dosing Varies So Much

Most discussion of 5-amino-1mq dosage subcutaneous comes down to individual trial and error rather than controlled comparison. Several factors push reported numbers in different directions:

  • Body weight: People who scale a rodent milligram-per-kilogram figure arrive at very different totals.
  • Injection site and technique: Absorption from abdominal fat versus thigh fat can differ, and technique errors change how much compound actually reaches tissue.
  • Purity and reconstitution: Research-grade powders vary in purity, and math mistakes during reconstitution change the delivered dose.
  • Unknown half-life: Without human pharmacokinetic data, nobody knows how long a dose stays active or whether daily use causes accumulation.

Any 5-amino-1mq dosage protocol circulating online is therefore a guess built on other people's guesses. Some websites offer a 5-amino-1mq dosage calculator, but a calculator built on anecdote cannot substitute for human pharmacokinetic data.

What a Typical Subcutaneous Routine Looks Like

A 5-amino-1mq subcutaneous injection dosage is not standardized, and the descriptions below reflect what users report rather than what is proven safe.

Injection basics

  • Injections are usually given into abdominal or thigh fat with a short insulin syringe.
  • Injection sites are rotated to reduce irritation and lumpy fat tissue.
  • Needles and syringes are single-use, and hands and skin are disinfected first.

Reconstitution and storage

  • Powder is typically mixed with bacteriostatic water, and the final concentration determines how many units equal a given dose.
  • Reconstituted vials are usually refrigerated and protected from light.
  • Sterile handling lowers infection risk but does not make an unapproved compound safe or effective.

When people search for a 5-amino-1mq dosage per day, they are usually looking for one fixed number. The honest answer is that no fixed number has been validated in humans.

Timing and Frequency Questions

Timing is another area where self-reported protocols differ. Some users inject in the morning, some fast before dosing, and others split the total into two smaller injections.

None of these patterns have been compared in a controlled human setting. Fasted versus fed dosing can change absorption for many compounds, but no data exist for 5-amino-1MQ in people, so no timing strategy can be called optimal.

5-Amino-1MQ is not FDA-approved for human use in the United States, and no clinical trial has established a safe or effective dose.

Reported side effects come only from user anecdotes and include injection-site irritation, fatigue, and digestive upset. Because NNMT is active in the liver, fat tissue, and nervous system, unintended effects on other pathways are plausible and unstudied.

Long-term risks, drug interactions, and effects during pregnancy or breastfeeding are unknown. Anyone considering this compound should talk with a licensed healthcare professional and should not treat forum protocols as medical guidance.

A More Realistic Way to Approach the Question

If you are researching 5-amino-1MQ, treat dose ranges as open questions rather than instructions. Practical steps include reading the primary rodent papers, checking whether any human trials have been registered, and asking a clinician about baseline and follow-up bloodwork.

Body-composition goals are generally better served by approaches with human safety data, including nutrition, resistance training, and FDA-approved medications prescribed by a physician. 5-Amino-1MQ remains an investigational molecule, and the absence of human data is the single most important fact about it.

Frequently Asked Questions

Is there an official 5-amino-1MQ dosage for humans?

No. 5-Amino-1MQ has not been tested in human clinical trials, so there is no official or FDA-recognized dose. The figures circulating online come from rodent studies and user anecdotes, and neither can establish safety or effectiveness in people.

Can you take 5-amino-1MQ orally instead of injecting it?

Rodent studies used oral gavage, so oral administration is scientifically plausible. Human oral bioavailability is unknown, and self-reported oral amounts are usually much larger than injectable amounts. Either route remains experimental and unverified in humans.

Is 5-amino-1MQ legal to buy in the United States?

5-Amino-1MQ is not approved as a prescription drug or a dietary supplement, and it is normally sold as a research chemical labeled for laboratory use only. Selling it for human consumption falls outside FDA rules, and buyers take on the risks of an unregulated product.

Research information notice

This page provides educational research information and does not replace medical advice, diagnosis, or treatment.